Background Pneumonia is an important cause of morbidity and mortality. COPD patients
using inhaled corticosteroids (ICS) have an increased risk of pneumonia, but less is known …

Aim Studies have linked the use of inhaled corticosteroids (ICSs) to excess pneumonia risk
in chronic obstructive pulmonary disease patients. The risk in asthma patients remains …

Background In clinical trials, the use of inhaled corticosteroids is associated with an
increased risk of pneumonia in people with COPD, but whether the same is true for people …

Background Inhaled corticosteroids (ICS) are associated with an increased risk of
pneumonia in patients with chronic obstructive pulmonary disease (COPD). Other factors …

Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …

Recent studies suggest that use of inhaled corticosteroids (ICS) in chronic obstructive
pulmonary disease (COPD) may be associated with a higher incidence of pneumonia …

Asthma patients have commonly been prescribed inhaled corticosteroids (ICSs) as the first
line of control therapy. ICSs are associated with an increased risk of pneumonia in chronic …

Rationale: Inhaled corticosteroids (ICS) are the mainstay of asthma treatment. Studies in
chronic obstructive pulmonary disease reported increased rates of pneumonia with ICS …

Purpose Asthma is a common disease that is expensive and burdensome for patients.
Inhaled corticosteroids (ICS) are the most important drugs for asthma treatment and are …

Objectives. To systematically review all available studies on inhaled corticosteroid use and
incident pneumonia in asthma patients. Methods. We performed a literature search from …